Dow Up1.63% Nasdaq Up0.97%

Novavax, Inc. (NVAX)

-NasdaqGS
4.88 0.28(5.52%) Oct 17, 4:00PM EDT
ProfileGet Profile for:
Novavax, Inc.
20 Firstfield Road
Gaithersburg, MD 20878
United States - Map
Phone: 240-268-2000
Website: http://www.novavax.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:213

Business Summary 

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. The company’s vaccine technology platform is based on proprietary recombinant nanoparticle vaccine technology that includes virus-like particles vaccines and protein nanoparticle vaccines. Its vaccine candidates target seasonal influenza, pandemic influenza, and respiratory syncytial virus. The company also develops technology for the production of immune stimulating saponin-based adjuvants. Novavax, Inc. has a clinical development agreement with PATH Vaccine Solutions to develop RSV vaccine candidate. The company was founded in 1987 and is headquartered in Gaithersburg, Maryland.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Novavax, Inc.

Corporate Governance 
Novavax, Inc.’s ISS Governance QuickScore as of Oct 1, 2014 is 8. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 8; Compensation: 8.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Stanley C. Erck , 66
Chief Exec. Officer, Pres, Director and Member of Fin. Committee
695.00K0.00
Mr. Barclay A. Phillips , 51
Chief Financial Officer, Principal Accounting Officer, Sr. VP and Treasurer
218.00K0.00
Dr. Gregory M. Glenn M.D., 60
Sr. VP of Corp. Devel.
515.00K0.00
Dr. Timothy Jon Hahn Ph.D., 50
Sr. VP of Global Manufacturing Operations
390.00K0.00
Mr. John Joseph Trizzino B.S., M.B.A., 54
Sr. VP of Commercial Operations
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders